Search Results - "Hyun, Ju‐Yong"

Peroxisome‐targeted Supramolecular Nanoprobes Assembled with Pyrene‐labelled Peptide Amphiphiles by Kim, Inhye, Bang, Woo‐Young, Kim, Sooyong, Jin, Seon‐Mi, Hyun, Ju‐Yong, Han, Eun Hee, Lee, Eunji

“…Despite the versatile metabolic functions of peroxisomes such as lipid synthesis and fatty acid oxidation and their relevance to genetically inherited…”
Get full text

Heterotypic cell-in-cell structures between cancer and NK cells are associated with enhanced anticancer drug resistance by Choe, Yun-Jeong, Min, Jin Young, Lee, Hyun-Seung, Lee, Sang-Yeop, Kwon, Joseph, Kim, Hye-Jin, Lee, Jangho, Kim, Hyun Min, Park, Hye Sun, Cho, Mi Young, Hyun, Ju-Yong, Kim, Hye Min, Chung, Yong-Ho, Ha, Sang Keun, Jeong, Hye Gwang, Choi, Inpyo, Kim, Tae-Don, Hong, Kwan Soo, Han, Eun Hee

“…The heterotypic CIC structures formed of cancer and immune cells have been observed in tumor tissues. We aimed to assess the feasibility of using heterotypic…”
Get full text

Optimal Revascularization Strategy in Non-ST-Segment-Elevation Myocardial Infarction With Multivessel Coronary Artery Disease: Culprit-Only Versus One-Stage Versus Multistage Revascularization by Kim, Min Chul, Hyun, Ju Yong, Ahn, Youngkeun, Bae, SungA, Hyun, Dae Young, Cho, Kyung Hoon, Sim, Doo Sun, Hong, Young Joon, Kim, Ju Han, Jeong, Myung Ho, Kim, Hyo-Soo, Gwon, Hyeon Cheol, Seong, In Whan, Hwang, Kyoung-Kook, Chae, Shung Chull, Hur, Seung Ho, Cha, Kwang Soo, Oh, Seok Kyu

“…Background Few studies have investigated optimal revascularization strategies in non-ST-segment-elevation myocardial infarction with multivessel disease. We…”
Get full text

Cover Feature: Peroxisome‐targeted Supramolecular Nanoprobes Assembled with Pyrene‐labelled Peptide Amphiphiles (Chem. Asian J. 22/2018) by Kim, Inhye, Bang, Woo‐Young, Kim, Sooyong, Jin, Seon‐Mi, Hyun, Ju‐Yong, Han, Eun Hee, Lee, Eunji

“…A peroxisome‐targetable supramolecular nanoprobe was developed based on the self‐assembly of peptide amphiphiles (PAs) in water. The nanostructured fluorescent…”
Get full text

Comparative effect of angiotensin converting enzyme inhibitor versus angiotensin ii type i receptor blocker in acute myocardial infarction with non-obstructive coronary arteries; from the Korea Acute Myocardial Infarction Registry — National Institute of Health by Ahn, Joon Ho, Hyun, Ju Yong, Jeong, Myung Ho, Kim, Ju Han, Hong, Young Joon, Sim, Doo Sun, Kim, Min Chul, Park, Hun-Sik, Kim, Doo-Il, Hur, Seung-Ho, Oh, Seok Kyu, Ahn, Youngkeun

“…BACKGROUND: Selecting angiotensin converting enzyme inhibitor (ACEI) or angiotensin II type I receptor blocker (ARB) in patients diagnosed as acute myocardial…”
Get full text